Related Experiment Video
Updated: Jul 16, 2026

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
Published on: May 5, 2023
Zorro locked nucleic acid induces sequence-specific gene silencing
Rongbin Ge1, Juhana E Heinonen, Mathias G Svahn
1Clinical Research Center, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, SE-141 86, Stockholm, Sweden. ge.rongbin@ki.se
Researchers developed "Zorro LNA," a novel molecule that blocks gene transcription in mammalian cells. This locked nucleic acid (LNA) analog offers a new, easily synthesized antigene drug for sequence-specific gene silencing.
Area of Science:
- Biochemistry
- Molecular Biology
- Drug Discovery
Background:
- Locked nucleic acids (LNAs) are synthetic nucleic acid analogs with a unique structural modification.
- Antigene molecules offer potential for sequence-specific gene regulation and therapeutic intervention.
Purpose of the Study:
- To develop and characterize a novel LNA-based antigene molecule, termed "Zorro LNA."
- To evaluate the efficacy of Zorro LNA in inhibiting gene transcription in a cellular context.
- To compare Zorro LNA's performance against linear LNA and peptide nucleic acid (PNA) constructs.
Main Methods:
- Synthesis of a novel "Zorro LNA" molecule designed for simultaneous binding to both DNA strands.
- Assessment of strand invasion into DNA duplexes.
- Evaluation of gene transcription inhibition in mammalian cells.
- Comparative analysis with linear LNA and optimized bisPNA oligonucleotides.
Main Results:
- Zorro LNA demonstrated effective and specific strand invasion into DNA duplexes.
- The Zorro LNA construct uniquely arrested gene transcription in mammalian cells.
- This represents the first instance of sequence-specific gene transcription blockade in mammalian cells using a nucleic acid analog with low, saturated binding.
- Zorro LNA showed potent inhibition of gene transcription in a cellular context.
Conclusions:
- Zorro LNA is a novel, sequence-specific antigene molecule with the unique ability to block gene transcription in mammalian cells.
- This LNA analog offers a new class of antigene drugs that are easy to synthesize.
- The findings present a novel strategy for sequence-specific gene silencing using nucleic acid analogs.
Related Concept Videos
Experimental RNAi
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
MicroRNAs
